Login
Toggle navigation
Videos
Categories
Trending
Acer CEO Explores the Future of AI-Powered PCs
10:00:00
Watch Full Video
×
Please Login to watch Full video
Login
+ ADD TO Wishlist
×
Please login
Login
Share On Facebook
Share On Twitter
Chairman and Chief Executive Officer Jason Chen has been Chairman and CEO of Acer since 2017.
Recent Videos
00:17:08
Urasar is 100% Hayasa Metals Inc. owned; our exploration license over the Urasar mineral district
00:10:00
Dryden Gold Secures $20M+ War Chest, Delivers High-Grade Discoveries and Expands Drill Targets Across Gold Rock District|Trey Wasser,CEO & Director,Dryden Gold 1
00:10:00
Mitchell Services Targets $50–60M EBITDA as Rig Utilization Drives Earnings Upside| Andrew Elf,CEO,Mitchell Services Limited
00:10:00
Lomiko Metals Reports Strong Pre-Feasibility Results with $800M NPV, Advancing High-Growth Graphite Projects|Gordana Slepcev,CEO,Lomiko Metals Inc.4
00:10:00
Generative AI Meets Wet Lab: Absci Accelerates Biologic Development with Hybrid Business Model|Sean McClain,CEO,Absci
00:10:00
Obliva Aims to Transform Lives of Children with Rare Mitochondrial Disorders|Ellen K. Donnelly ,CEO,Abliva AB7
00:10:00
Abionic Repositions Bio-HDL Therapy CCR001 for Rare Kidney and Eye Disorders with Promising Early Results|Cyrille Tupin,CEO,ABIONYX Pharma
00:10:00
Abingdon Health Reports 45% H1 Revenue Growth Amid Strategic Expansion and Large Contract Wins|Dr Chris Hand,Chairman,Abingdon Health
00:10:00
EB-101 Gene Therapy Shows Promising Results in Treating Recessive Dystrophic EB|Vishwas Seshadri,CEO,Abeona Therapeutics
00:10:00
Revolutionizing Trauma Care: How AAP’s Silver Technology is Fighting Deadly Implant Infections|Rubino Di Girolamo,CEO,aap Implantate AG
00:10:00
Revolutionizing Cancer Treatment: Tumor-Agnostic mTOR Targeting Shows Breakthrough Success in Rare and Genetic-Driven Tumors| Neil Desai, Founder, Executive Chairman ,Aadi Bioscience
00:10:00
Millions Affected, No Approved Cure: 89bio Advances New Therapy for NASH|Rohan Palekar,CEO,89bio Inc2
00:10:00
Malaria Prevention Drug Arakoda Positioned to Drive Future Growth for 60 Degrees Pharmaceuticals|Geoffrey Dow,President,60 Degrees Pharmaceuticals
00:10:00
4DMedical Revolutionizes Lung Imaging with CTVQ: Turning a Simple CT Scan into Functional Lung Diagnostics|Dr Andreas Fouras,CEO,4Dmedical Ltd
00:10:00
4DMedical Revolutionizes Lung Imaging with CTVQ: Turning a Simple CT Scan into Functional Lung Diagnostics|Dr Andreas Fouras,CEO,4Dmedical Ltd
00:10:00
4basebio CEO Heikki Lanckriet Unveils Vision for Next-Generation Synthetic DNA and Gene Therapy Components|Heikki Lanckriet,CEO,4basebio
Suggestions
00:10:00
combined experience building the own companies|Hadley Harris,Co-Founder,Eniac Ventures
00:10:00
Russophobia and Anti-Semitism in Russian Nationalism: A Complex Nexus|Gary Saul Morson,Professor,Northwestern University
00:10:00
Unmasking the Pitfalls: How Media Impacts Investor Decisions
00:10:00
There are many real use cases across financial services|Seth Rosenberg,Investor,Greylock
00:10:00
Highfield Resources: Advancing the Profitable Muga Potash Project in Spain
00:10:00
CEO Spotlight: Benjamin Lightburn on Filament Health's Mission and Milestones | Benjamin Lightburn, CEO , Filament Health Corp.
00:00:00
Jan Anders Karlsson, CEO, Verona Pharma
00:10:00
Scott Kettle: Innovating Global Digital Distribution with Gawk Incorporated
00:10:00
In an interview, Torsten Redlich, Global Head of Business Development for Division eHealth at secunet Security Networks AG, shares insights.
00:10:00
TechCentral Impact Series: Evolution of Cybersecurity with CYBER1 Solutions and Palo Alto Networks | Robert Brown, CEO of Cyber Security 1 AB
00:10:00
Jake Klein, Executive Chair of Evolution Mining, discusses his journey and updates on Evolution's operations, including the Cowal Gold Mine, Ernest Henry, Mt Rawden, and Red Lake projects.|Jake Klein, Executive Chair of Evolution Mining,
00:10:00
American Rare Earths CEO Highlights Major US Rare Earth Projects and Upcoming NASDAQ Listing